EMBL Australia

A study led by EMBL Australia Group Leader Dr Michelle Boyle has uncovered a potential breakthrough in malaria treatment using anti-inflammatory drug ruxolitinib to both reduce harmful inflammation and boost immune protection against malaria.

EMBL Australia group leader Professor Eduardo Eyras has been appointed as Director of the Shine‑Dalgarno Centre for RNA Innovation.

EMBL Australia researchers and alumni have been awarded more than $7 million in recent grant funding, enabling ambitious new research projects that push the boundaries of fundamental science across our network.

More than 60 PhD students from across the country came together in Adelaide for the 10th EMBL Australia PhD Course – a unique, two-week residential program designed to equip emerging researchers with the skills and confidence needed for modern scientific careers.

News this quarter:

• Seeking an EMBL Australia group leader in neural regeneration
• Building a global RI ecosystem: Stronger together at Prato 2025
• New leaders join the EMBL Australia Steering Committee
• Building global connections in life science infrastructure
• Cost-effective imaging technology to revolutionise spatial transcriptomics
• Meet our PhD Course partners
• A smarter future for Australian biobanks

And more:

• Job opportunities
• Upcoming events
• Training at EMBL
• Recent publications

Senior representatives from Australia’s national research infrastructures (RIs) visited EMBL sites in Europe to explore how shared platforms can accelerate discovery across biology, engineering and computation.

The 2025 Australian and European Health Research Infrastructure Symposium brought together Australian and international research infrastructure (RI) communities from health and the life sciences to strengthen international partnerships and tackle shared challenges.

EMBL Australia is pleased to announce the expansion of its Partner Laboratory Network Steering Committee, welcoming new senior representatives from leading research institutions across the country.

Professor Peter Currie, Director of Research at the Australian Regenerative Medicine Institute (ARMI) at Monash University and EMBL Australia ARMI Institutional Representative, has been elected as an Associate Member of the European Molecular Biology Organization (EMBO), in recognition of his scientific achievements in regenerative biology.

EMBL Australia group leader Dr William Roman & his team have launched a new imaging-based spatial transcriptomics platform that dramatically reduces experimental costs from more than $35,000 to approximately $30 per experiment, making spatial biology more accessible to researchers across Australia.